Right ventricule-specific therapies in ARDS: other vasodilating agents to be considered
Crossref DOI link: https://doi.org/10.1186/s13054-023-04419-4
Published Online: 2023-04-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ymeraj, Senada
Attou, Rachid
Redant, Sebastien
Text and Data Mining valid from 2023-04-03
Version of Record valid from 2023-04-03
Article History
Received: 22 March 2023
Accepted: 27 March 2023
First Online: 3 April 2023
Declarations
:
: Not applicable.
: The authors declare to have no competing interests.